The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly

The Management of Combined Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Particularly Complex Challenge, Especially in the Elderly

Anticoagulation is superior to dual antiplatelet therapy (DAPT) in the prevention of thromboembolic events in patients with atrial fibrillation (AF), otherwise the prevention of ischemic risk and stent thrombosis after percutaneous coronary intervention (PCI) is warranted by DAPT. The coexistence of...

Full description

Bibliographic Details
Main Authors:	Leonardo Bencivenga, Klara Komici, Graziamaria Corbi, Antonio Cittadini, Nicola Ferrara, Giuseppe Rengo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-07-01
Series:	Frontiers in Physiology
Subjects:	antithrombotic therapy anticoagulation antiplatelet atrial fibrillation percutaneous coronary intervention elderly
Online Access:	https://www.frontiersin.org/article/10.3389/fphys.2018.00876/full

Similar Items

Evolving Antithrombotic Treatment Patterns for Patients With Nonvalvular Atrial Fibrillation and Acute Coronary Syndrome or Underwent Percutaneous Coronary Intervention in China: A Cross-Sectional Study
by: Ni Suo, et al.
Published: (2022-03-01)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
by: Wilbert Bor, et al.
Published: (2020-06-01)

Post‐Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation
by: Shin‐Yi Lin, et al.
Published: (2022-03-01)

Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis
by: Davide Capodanno, et al.
Published: (2020-08-01)

Current Guidelines on Antithrombotic Management in Patients Undergoing Gastrointestinal Endoscopy
by: Muhammad Begawan Bestari, et al.
Published: (2019-05-01)

Net clinical benefit of antithrombotic therapy for atrial fibrillation patients with stable coronary artery disease
by: So-Ryoung Lee, et al.
Published: (2022-08-01)

Gastrointestinal Endoscopy in Patients Receiving Antithrombotic Therapy
by: Supriadi Supriadi, et al.
Published: (2021-09-01)

COMBINED ANTITHROMBOTIC THERAPY IN CASE OF PLANNED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ATRIAL FIBRILLATION IN ACTUAL CLINICAL PRACTICE
by: N. Yu. Khorkova, et al.
Published: (2018-12-01)

Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
by: Abdelmoniem Moustafa, et al.
Published: (2019-10-01)

Antithrombotic Therapy for Atrial Fibrillation and Coronary Artery Disease in Patients With Prior Atherothrombotic Disease: A Post Hoc Analysis of the AFIRE Trial
by: Yasushi Matsuzawa, et al.
Published: (2021-11-01)

High Mortality Rates Among Patients With Non‐Traumatic Intracerebral Hemorrhage and Atrial Fibrillation on Antithrombotic Therapy Are Independent of the Presence of Cerebral Amyloid Angiopathy: Insights From a Population‐Based Study
by: Shiva P. Ponamgi, et al.
Published: (2020-08-01)

Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study
by: Jiesuck Park, et al.
Published: (2021-04-01)

Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
by: Yongqiang Fan, et al.
Published: (2022-02-01)

Optimisation of oral anticoagulants for patients with atrial fibrillation within 12 months after percutaneous coronary intervention: A meta-analysis and systematic review
by: Shuo Wang, et al.
Published: (2021-10-01)

Changes in Antithrombotic Therapy Prescription in Patients with a Combination of Atrial Fibrillation and Myocardial Infarction in a Specialised Inpatient Department from 2016–2019 and Associations with Prognosis
by: Sergey Stepanovich Yakushin, et al.
Published: (2023-08-01)

Does Antithrombotic Therapy Affect Outcomes in Major Trauma Patients? A Retrospective Cohort Study from a Tertiary Trauma Centre
by: Stefano Sartini, et al.
Published: (2022-09-01)

Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature
by: Razvan I. Radu, et al.
Published: (2021-12-01)

Antithrombotics prescription and adherence among stroke survivors: A systematic review and meta‐analysis
by: Min Yang, et al.
Published: (2022-10-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES
by: Ya. P. Dovgalevskiy, et al.
Published: (2016-01-01)

Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study
by: Lukas Andreas Heger, et al.
Published: (2020-09-01)

Poor outcomes associated with antithrombotic undertreatment in patients with atrial fibrillation attending Gondar University Hospital: a retrospective cohort study
by: Eyob Alemayehu Gebreyohannes, et al.
Published: (2018-09-01)

Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
by: Gwang-Seok Yoon, et al.
Published: (2021-07-01)

Antithrombotic Treatment and Its Association with Outcome in a Multicenter Cohort of Transcatheter Edge-to-Edge Mitral Valve Repair Patients
by: Christian Waechter, et al.
Published: (2022-10-01)

Antithrombotic therapy and its impact on prognosis in patients with atrial fibrillation and myocardial infarction. Long-term observation results
by: Mariia V. Soloveva, et al.
Published: (2021-10-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

Pharmacokinetic and Pharmacogenetic Predictors of Major Bleeding Events in Patients with an Acute Coronary Syndrome and Atrial Fibrillation Receiving Combined Antithrombotic Therapy
by: Olga Baturina, et al.
Published: (2023-09-01)

Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment
by: Ignacio Barriuso, et al.
Published: (2022-11-01)

Management of antithrombotic agents and current issues in patients undergoing endoscopic submucosal dissection
by: Chan Hyuk Park
Published: (2019-07-01)

Emergence of institutional antithrombotic protocols for coronavirus 2019
by: Kevin P. Cohoon, et al.
Published: (2020-05-01)

Intelligent antithrombotic nanomedicines: Progress, opportunities, and challenges
by: Junchao Xu, et al.
Published: (2021-04-01)

Analysis of the consumption volumes of antithrombotic drugs used for pharmacotherapy of atrial fibrillation in Saratov Region
by: А. V. Sokolov, et al.
Published: (2022-01-01)

Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials
by: Su-Kiat Chua, et al.
Published: (2020-04-01)

Prognostic impact of a history of cancer and atrial fibrillation in antithrombotic therapy for chronic heart failure
by: Kotaro Nochioka, et al.
Published: (2022-08-01)

Antithrombotic therapy after transcatheter aortic valve replacement
by: Tariq A.M. Mousa, et al.
Published: (2022-01-01)

Experimental antithrombotic effect of medicinal plants: A critical review
by: Shweta Mandloi, et al.
Published: (2022-01-01)

Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry
by: Eleonora Gaetani, et al.
Published: (2020-06-01)

Antithrombotics from the Sea: Polysaccharides and Beyond
by: Francisca Carvalhal, et al.
Published: (2019-03-01)

Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation
by: Jarosław Zalewski, et al.
Published: (2016-11-01)

Antithrombotic Strategies in Patients with Atrial Fibrillation and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
by: Leonardo De Luca, et al.
Published: (2022-01-01)

Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI
by: Rosanne F. Vogel, et al.
Published: (2022-09-01)